Arkolith/Insider Trading/IBRX/Form 4

Cohen Cheryl

DirectorImmunityBio, Inc. (IBRX) · full profile →Form 4 · filed Jul 7, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.2M
Net Open-Market Flow
-$1.2M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 2, 2026Option exercise(M)56K$2.98$167K257K
Jul 2, 2026Sell(S)131K$9.50$1.2M125K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 2, 2026Option exercise(M)56K—$0112K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001529371-26-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML